98 related articles for article (PubMed ID: 2151370)
21. Echocardiographic and electrocardiographic findings in juvenile hypertension.
Niederle P; Widimský J; Jandová R
Cor Vasa; 1981; 23(4):257-64. PubMed ID: 6457730
[TBL] [Abstract][Full Text] [Related]
22. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study.
Barrios V; Calderón A; Escobar C; Barrios S; Navarro-Cid J; González-Pedel V; Vegazo O; Fernandez R
J Hypertens; 2007 Sep; 25(9):1967-73. PubMed ID: 17762663
[TBL] [Abstract][Full Text] [Related]
23. Effects of drug therapy on hypertensive left ventricular hypertrophy.
Fletcher PJ; Horvath JS; Bailey BP; Tiller D
Clin Exp Pharmacol Physiol; 1985; 12(3):291-4. PubMed ID: 3161673
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.
Savage DD; Garrison RJ; Kannel WB; Levy D; Anderson SJ; Stokes J; Feinleib M; Castelli WP
Circulation; 1987 Jan; 75(1 Pt 2):I26-33. PubMed ID: 2947749
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular hypertrophy: relationship of echocardiographic and electrocardiographic findings in idiopathic dilated cardiomyopathy.
Kiatchoosakun S; Mahanonda N; Phankingthongkum R; Wansanit K; Kangkagate C; Sahasakul Y; Jootar P; Chaithiraphan S
J Med Assoc Thai; 1996 Feb; 79(2):103-7. PubMed ID: 8868021
[TBL] [Abstract][Full Text] [Related]
26. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
27. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients.
Yasumoto K; Takata M; Yoshida K; Mikawa M; Tomoda F; Sasayama S
J Hum Hypertens; 1990 Feb; 4(1):13-8. PubMed ID: 1971654
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of the electrocardiographic diagnosis of left ventricular hypertrophy on the basis of gender].
Calaça J; Martins P; Mota T; de Almeida R; Ribeiro I; Cotta C; Lousada N; Ramos A; Pereira T; Correia M
Rev Port Cardiol; 1990 Dec; 9(12):959-62. PubMed ID: 2151204
[TBL] [Abstract][Full Text] [Related]
29. [Regression of left ventricular hypertophy in the ECG during antihypertensive treatment: preliminary observations (author's transl)].
Manegold C; Patzschke U
Dtsch Med Wochenschr; 1979 Jun; 104(23):846-8. PubMed ID: 156115
[TBL] [Abstract][Full Text] [Related]
30. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.
Liebson PR
Am J Hypertens; 1990 Jun; 3(6 Pt 1):512-7. PubMed ID: 2142430
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.
Reichek N; Devereux RB
Circulation; 1981 Jun; 63(6):1391-8. PubMed ID: 6452972
[TBL] [Abstract][Full Text] [Related]
32. Reversal of left ventricular hypertrophy with captopril: heterogeneity of response among hypertensive patients.
Mujais SK; Fouad FM; Tarazi RC
Clin Cardiol; 1983 Dec; 6(12):595-602. PubMed ID: 6229379
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Left Ventricular Hypertrophy by Electrocardiography and Echocardiography in Children Using Analytics Tool.
Tague L; Wiggs J; Li Q; McCarter R; Sherwin E; Weinberg J; Sable C
Pediatr Cardiol; 2018 Oct; 39(7):1378-1388. PubMed ID: 29774391
[TBL] [Abstract][Full Text] [Related]
34. Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension.
Loirat C; Azancot A; Pillion G; Macher MA; Mouchet B; Gainet B; Mathieu H
Clin Exp Hypertens A; 1986; 8(4-5):805-10. PubMed ID: 2944675
[TBL] [Abstract][Full Text] [Related]
35. Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy.
Antman EM; Green LH; Grossman W
Circulation; 1979 Aug; 60(2):386-96. PubMed ID: 156094
[TBL] [Abstract][Full Text] [Related]
36. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
Rosales OR; Sander GE; Roffidal L; Given MB; Giles TD
Chest; 1989 Jan; 95(1):43-7. PubMed ID: 2521204
[TBL] [Abstract][Full Text] [Related]
37. ECG-gated cardiac scan and echocardiographic assessments of left ventricular hypertrophy: reversal by 6-month treatment with diltiazem.
Senda Y; Tohkai H; Kimura M; Shida Y; Tutumi S; Koshiyama H; Tanaka T; Shimaji Y; Nogita T
J Cardiovasc Pharmacol; 1990 Aug; 16(2):298-304. PubMed ID: 1697387
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy in children with rheumatic heart disease.
Sastroasmoro S; Madiyono B; Oesman IN
Paediatr Indones; 1991; 31(9-10):233-44. PubMed ID: 1838145
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
Kannel WB; Levy D; Cupples LA
J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
[TBL] [Abstract][Full Text] [Related]
40. Echocardiographic diagnosis of left ventricular hypertrophy.
McFarland TM; Alam M; Goldstein S; Pickard SD; Stein PD
Circulation; 1978 Jun; 57(6):1140-4. PubMed ID: 147758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
